Free Trial
→ Elon’s “New Gold” (From True Market Insiders) (Ad) Free YSBPW Stock Alerts

YS Biopharma (YSBPW) SEC Filings & 10K Form

$0.06 0.00 (0.00%)
As of 03/7/2025
Compare

Recent YS Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
12/19/2024
8:28 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
3:10 PM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
7:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2024
3:01 PM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
8:16 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
7:40 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2024
7:59 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
6:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2024
3:00 PM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K/A
09/10/2024
7:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
7:10 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
7:40 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
6:28 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/31/2024
6:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form NT 20-F
07/05/2024
6:15 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
6:30 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2024
6:01 AM		LakeShore Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
LakeShore Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
6:45 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
3:30 PM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2024
3:16 PM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/08/2024
7:32 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 424B3
04/29/2024
7:15 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
7:03 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
7:15 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
7:20 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2024
7:10 AM		YS Biopharma Co., Ltd. (Filer)
YS Biopharma (Filer)
YS Biopharma Co., Ltd. (Filer)
YS Biopharma Co., Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:YSBPW) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners
Former CIA to Trump – Will you Shut down this secret lab?
Deep in the sands of New Mexico lies a government lab so secret it makes Area 51 look like a tourist spot… ...
Paradigm Press | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...
Crypto Swap Profits | Sponsored
March 18th: Gold SHOCK?
On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic…...
InvestorPlace | Sponsored
Urgent Bitcoin alert for RIGHT NOW
Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...
Brownstone Research | Sponsored
Musk’s real agenda in Washington…
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...
Porter & Company | Sponsored
DeFi Coin on Verge of Breakout!
We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years.
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored